Close
Close
Treatment Database
sorafenib
Trade Name not avaiable
Orphan Indication Desmoid tumors/aggressive fibromatosis
USA Market Approval
USA Designation Date 28-02-2019
Sponsor Bayer HealthCare Pharmaceuticals, Inc.
100 Bayer Boulevard, P.O. Box 915
Whippany, New Jersey, 07981
More about Fibromatosis
Free Newsletter
Videos
by Abidemi Uruejoma
7 views
by Abidemi Uruejoma
19 views
by Abidemi Uruejoma
24 views
by Abidemi Uruejoma
53 views